Novo Nordisk's pricing strategies during the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of cost gouging, stating the stark contrast between U.S. prices and those in Europe and copyright. But Rybelsus and copyright do have some dissimil